Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases

I. Puxeddu, F. Bongiorni, D. Chimenti, S. Bombardieri, A. Moretta, C. Bottino, P. Migliorini

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objectives: A defined role for natural killer (NK) cells and their activating receptors in autoimmunity has not been clearly established. The aim of this study was to evaluate the levels of the CD3-CD56+NK cells and their expression of receptors and co-receptors in the peripheral blood of patients with systemic autoimmune disorders. Methods: Thirty-four subjects with systemic sclerosis (SSc), 14 with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), 14 with systemic lupus erythematosus (SLE), and 14 healthy donors were studied. The activating receptors NKp46, NKp44, NKp30, NKG2D, and DNAM-1 and the co-receptors NTB-A and 2B4 were analysed by flow cytometry on peripheral blood NK cells. Results: In SSc, AAV, and SLE we detected a significant decrease in the percentage of CD3-CD56+ NK cells compared to healthy controls. No differences in the expression of NKp46, NKp44, and NKp30 were identified. On the contrary, NKG2D and DNAM-1 expression was decreased in SLE, but not in SSc and AAV, NTB-A was decreased in SLE, and 2B4 in both SLE and SSc. No differences were detected between active and inactive SLE patients. In SSc, only patients affected by pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) had a low expression of DNAM-1, 2B4, and NKp30. Conclusions: These data demonstrate that patients with different systemic autoimmune diseases differ in the expression of activating receptors and co-receptors on CD3-CD56+ NK cells. The down-regulation of receptors and co-receptors in SSc with lung involvement suggests their possible role in this manifestation of the disease.

Original languageEnglish
Pages (from-to)298-304
Number of pages7
JournalScandinavian Journal of Rheumatology
Volume41
Issue number4
DOIs
Publication statusPublished - 2012

Fingerprint

Systemic Scleroderma
Natural Killer Cells
Systemic Lupus Erythematosus
Autoimmune Diseases
Blood Cells
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Natural Cytotoxicity Triggering Receptor 2
Natural Cytotoxicity Triggering Receptor 1
Natural Killer Cell Receptors
Interstitial Lung Diseases
Autoimmunity
Pulmonary Hypertension
Flow Cytometry
Down-Regulation
Tissue Donors
Lung

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases. / Puxeddu, I.; Bongiorni, F.; Chimenti, D.; Bombardieri, S.; Moretta, A.; Bottino, C.; Migliorini, P.

In: Scandinavian Journal of Rheumatology, Vol. 41, No. 4, 2012, p. 298-304.

Research output: Contribution to journalArticle

Puxeddu, I. ; Bongiorni, F. ; Chimenti, D. ; Bombardieri, S. ; Moretta, A. ; Bottino, C. ; Migliorini, P. / Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases. In: Scandinavian Journal of Rheumatology. 2012 ; Vol. 41, No. 4. pp. 298-304.
@article{067ae2a9c12f453eadc204083f9fb147,
title = "Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases",
abstract = "Objectives: A defined role for natural killer (NK) cells and their activating receptors in autoimmunity has not been clearly established. The aim of this study was to evaluate the levels of the CD3-CD56+NK cells and their expression of receptors and co-receptors in the peripheral blood of patients with systemic autoimmune disorders. Methods: Thirty-four subjects with systemic sclerosis (SSc), 14 with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), 14 with systemic lupus erythematosus (SLE), and 14 healthy donors were studied. The activating receptors NKp46, NKp44, NKp30, NKG2D, and DNAM-1 and the co-receptors NTB-A and 2B4 were analysed by flow cytometry on peripheral blood NK cells. Results: In SSc, AAV, and SLE we detected a significant decrease in the percentage of CD3-CD56+ NK cells compared to healthy controls. No differences in the expression of NKp46, NKp44, and NKp30 were identified. On the contrary, NKG2D and DNAM-1 expression was decreased in SLE, but not in SSc and AAV, NTB-A was decreased in SLE, and 2B4 in both SLE and SSc. No differences were detected between active and inactive SLE patients. In SSc, only patients affected by pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) had a low expression of DNAM-1, 2B4, and NKp30. Conclusions: These data demonstrate that patients with different systemic autoimmune diseases differ in the expression of activating receptors and co-receptors on CD3-CD56+ NK cells. The down-regulation of receptors and co-receptors in SSc with lung involvement suggests their possible role in this manifestation of the disease.",
author = "I. Puxeddu and F. Bongiorni and D. Chimenti and S. Bombardieri and A. Moretta and C. Bottino and P. Migliorini",
year = "2012",
doi = "10.3109/03009742.2011.648657",
language = "English",
volume = "41",
pages = "298--304",
journal = "Scandinavian Journal of Rheumatology",
issn = "0300-9742",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases

AU - Puxeddu, I.

AU - Bongiorni, F.

AU - Chimenti, D.

AU - Bombardieri, S.

AU - Moretta, A.

AU - Bottino, C.

AU - Migliorini, P.

PY - 2012

Y1 - 2012

N2 - Objectives: A defined role for natural killer (NK) cells and their activating receptors in autoimmunity has not been clearly established. The aim of this study was to evaluate the levels of the CD3-CD56+NK cells and their expression of receptors and co-receptors in the peripheral blood of patients with systemic autoimmune disorders. Methods: Thirty-four subjects with systemic sclerosis (SSc), 14 with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), 14 with systemic lupus erythematosus (SLE), and 14 healthy donors were studied. The activating receptors NKp46, NKp44, NKp30, NKG2D, and DNAM-1 and the co-receptors NTB-A and 2B4 were analysed by flow cytometry on peripheral blood NK cells. Results: In SSc, AAV, and SLE we detected a significant decrease in the percentage of CD3-CD56+ NK cells compared to healthy controls. No differences in the expression of NKp46, NKp44, and NKp30 were identified. On the contrary, NKG2D and DNAM-1 expression was decreased in SLE, but not in SSc and AAV, NTB-A was decreased in SLE, and 2B4 in both SLE and SSc. No differences were detected between active and inactive SLE patients. In SSc, only patients affected by pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) had a low expression of DNAM-1, 2B4, and NKp30. Conclusions: These data demonstrate that patients with different systemic autoimmune diseases differ in the expression of activating receptors and co-receptors on CD3-CD56+ NK cells. The down-regulation of receptors and co-receptors in SSc with lung involvement suggests their possible role in this manifestation of the disease.

AB - Objectives: A defined role for natural killer (NK) cells and their activating receptors in autoimmunity has not been clearly established. The aim of this study was to evaluate the levels of the CD3-CD56+NK cells and their expression of receptors and co-receptors in the peripheral blood of patients with systemic autoimmune disorders. Methods: Thirty-four subjects with systemic sclerosis (SSc), 14 with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), 14 with systemic lupus erythematosus (SLE), and 14 healthy donors were studied. The activating receptors NKp46, NKp44, NKp30, NKG2D, and DNAM-1 and the co-receptors NTB-A and 2B4 were analysed by flow cytometry on peripheral blood NK cells. Results: In SSc, AAV, and SLE we detected a significant decrease in the percentage of CD3-CD56+ NK cells compared to healthy controls. No differences in the expression of NKp46, NKp44, and NKp30 were identified. On the contrary, NKG2D and DNAM-1 expression was decreased in SLE, but not in SSc and AAV, NTB-A was decreased in SLE, and 2B4 in both SLE and SSc. No differences were detected between active and inactive SLE patients. In SSc, only patients affected by pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) had a low expression of DNAM-1, 2B4, and NKp30. Conclusions: These data demonstrate that patients with different systemic autoimmune diseases differ in the expression of activating receptors and co-receptors on CD3-CD56+ NK cells. The down-regulation of receptors and co-receptors in SSc with lung involvement suggests their possible role in this manifestation of the disease.

UR - http://www.scopus.com/inward/record.url?scp=84863949160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863949160&partnerID=8YFLogxK

U2 - 10.3109/03009742.2011.648657

DO - 10.3109/03009742.2011.648657

M3 - Article

VL - 41

SP - 298

EP - 304

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

SN - 0300-9742

IS - 4

ER -